Literature DB >> 9650603

Radon-progeny exposure and lung cancer risk in a cohort of Newfoundland fluorspar miners.

H I Morrison1, P J Villeneuve, J H Lubin, D E Schaubel.   

Abstract

Although radon is a well-established lung carcinogen, there are uncertainties concerning the exposure-response relationship, whether exposures in early life are particularly hazardous, and how smoking affects the risks associated with radon exposure. A cohort study of the mortality experience of 1,743 underground fluorspar miners and 321 surface workers from 1950 to 1984 reported previously has been extended to include 6 additional years of follow-up (1985-1990). A statistically significant relationship was noted between radon-progeny exposure and risk of lung cancer mortality. Our analysis found no effect for age at first exposure. Attained age was strongly predictive of excess relative risk (ERR) per working level month (WLM) of radon exposure, falling from 0.025 for those aged less than 50 years to 0.002 for those 70 years or older. An inverse exposure-rate effect was also observed, wherein for equal total exposure, a high exposure rate (and short duration) is less harmful than a low exposure rate (and long duration). The ERR/WLM increased from 0.0019 for exposures of less than 10 years to 0.0076 for exposures of 20 or more years. The analysis of time-since-exposure windows revealed a greater ERR/WLM for exposures received in more recent periods, similar to the result for time since last exposure. Excess relative risks per WLM were higher for current smokers than for nonsmokers (never and former smokers). Analyses were consistent with a multiplicative relationship between radon-progeny exposure and current smoking and the risk of lung cancer. The assessment of radon exposure and lung cancer risk should incorporate the effects of exposure rate, time since exposure, smoking status and attained age.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9650603

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

1.  Mortality analyses in the updated French cohort of uranium miners (1946-2007).

Authors:  E Rage; S Caër-Lorho; D Drubay; S Ancelet; P Laroche; D Laurier
Journal:  Int Arch Occup Environ Health       Date:  2014-11-20       Impact factor: 3.015

2.  Coronary heart disease mortality and radon exposure in the Newfoundland fluorspar miners' cohort, 1950-2001.

Authors:  Paul J Villeneuve; Rachel S D Lane; Howard I Morrison
Journal:  Radiat Environ Biophys       Date:  2007-04-24       Impact factor: 1.925

3.  Radon-associated lung cancer risk among French uranium miners: modifying factors of the exposure-risk relationship.

Authors:  Blandine Vacquier; Agnès Rogel; Klervi Leuraud; Sylvaine Caer; Alain Acker; Dominique Laurier
Journal:  Radiat Environ Biophys       Date:  2008-10-24       Impact factor: 1.925

Review 4.  Cumulative risk assessment: an overview of methodological approaches for evaluating combined health effects from exposure to multiple environmental stressors.

Authors:  Ken Sexton
Journal:  Int J Environ Res Public Health       Date:  2012-01-26       Impact factor: 3.390

Review 5.  Understanding the human health effects of chemical mixtures.

Authors:  David O Carpenter; Kathleen Arcaro; David C Spink
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

6.  If cumulative risk assessment is the answer, what is the question?

Authors:  Michael A Callahan; Ken Sexton
Journal:  Environ Health Perspect       Date:  2007-01-24       Impact factor: 9.031

7.  Assessing cumulative health risks from exposure to environmental mixtures - three fundamental questions.

Authors:  Ken Sexton; Dale Hattis
Journal:  Environ Health Perspect       Date:  2007-01-24       Impact factor: 9.031

8.  Effective Strategies for Monitoring and Regulating Chemical Mixtures and Contaminants Sharing Pathways of Toxicity.

Authors:  Arjun K Venkatesan; Rolf U Halden
Journal:  Int J Environ Res Public Health       Date:  2015-08-28       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.